CDEK
← All trials

NCT07296718

Phase 4Interventional

Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.

View on ClinicalTrials.gov ↗

Timeline

Start date
May 15, 2023
Primary completion
Nov 15, 2023
Completion date
Oct 15, 2025
First posted
Dec 22, 2025
Last posted
Dec 22, 2025
Enrollment
249
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.